Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Samsung Biologics (207940) – Hana Securities | Post-Spinoff Profitability · Record KRW 6.8T Orders · Plant 6 Groundbreaking Visibility / 2026-01-07 Research
  • [Research] Hanwha Ocean (042660) – Daishin | Early Offshore Revenue · Naval Defense Pipeline · Excessive Discount / 2026-07-09 Research
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI Demand · Supply Tightness · Margin Expansion / 2026-08-11 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | Memory Pricing · Cash Flow · Shareholder Returns / 2026-01-30 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Long-term Exclusive Contracts · 2029 Target EPS · Structural ASP Hikes / 2026-06-01 Research
  • [Research] LIG D&A (079550) – iM Securities | Export Pipeline · CapEx & Hiring Expansion · Global Air Defense Growth / 2026-08-07 Research
  • [Research] ABL Bio (298380) – DS Investment & Securities | ABL001 Data Readout · ABL111 Phase 3 · Grabody B Expansion / 2026-04-07 Research
  • [Research] Samsung Biologics (207940) – iM Securities | New Plant Operations · PolyPeptide Acquisition · Portfolio Diversification / 2026-07-24 Research

[Research] SK hynix (000660 / SKHY) – Mirae Asset | DRAM Pricing · Big Tech Demand · Earnings Upgrades / 2026-01-19

Posted on January 19, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Mirae Asset Securities

Analyst : Younggun Kim (RA: Sehoon Jung)

Investment Rating : BUY

Target Price : 956,000 KRW (Raised)

Core Momentum : Extreme DRAM supply-demand imbalances and strong purchasing capacity from big-tech customers are expected to sustain historically elevated pricing, driving substantial ASP growth and upward revisions to 2026 earnings.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price: 956,000 KRW (Based on P/B 3.0x, reflecting a 17.9% upward revision in 2026F OP to 128 trillion KRW)
  • Investment Rating: BUY
  • 2026F Financial Outlook: Revenue 229.56 trillion KRW, Operating Profit 128.11 trillion KRW, Net Income 107.51 trillion KRW
  • EPS: 147,684 KRW (2026F)
  • Valuation Multiples: PER 5.1x, PBR 2.5x, ROE 64.0% (Based on 2026F)

🚀 2. [Market Opportunities & Business Outlook]

  • Price Surge Drivers: According to Trendforce data, PC DRAM DDR5 16Gb chip prices are projected to reach $32.4 by 4Q26, nearing levels once deemed abnormal for DDR4 16Gb chips ($32.1) amid extreme supply tightness.
  • Bit-Cost Analysis: Converting unit chip prices into bit-based pricing yields $2.0/Gb, far exceeding the historical peak threshold of $1.0/Gb seen in past super-cycles. Since the estimated DRAM pass-through pricing for cloud providers such as AWS and GCS reaches $12–39/Gb+, their purchasing capacity remains virtually unrestricted.
  • Earnings Outlook: DRAM suppliers are prioritizing big tech demand, with ultra-large OEMs securing long-term contracts at elevated pricing baselines. 2026F DRAM ASP is estimated at $1.0/Gb (+77% YoY), driving projected full-year revenue and operating profit to 230 trillion KRW and 128 trillion KRW, respectively.

📝 Editor’s Comment (Perspective)

The analyst views SK hynix as an enterprise capturing historic price surges reminiscent of past supplier restructuring cycles, achieving record-breaking earnings amid extreme market imbalances. The analyst highlights explosive ASP appreciation and successful alignment with big-tech demand.

To verify this investment thesis, one should track whether actual 4Q26 PC DRAM prices meet Trendforce projections, if big-tech long-term contract momentum and bit-based ASP growth translate into actual financial results, and whether the 2026 targets of 230 trillion KRW in revenue and 128 trillion KRW in operating profit are successfully realized. These indicators can be monitored through upcoming quarterly reports and regulatory filings via DART.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] Samsung SDI (006400) – Mirae Asset Securities | Hypothetical SDC Stake Monetization · North American ESS Acceleration · Valuation Appeal / 2026-01-19
Next Post: [Research] SK hynix (000660 / SKHY) – Eugene Investment | HBM Demand · AI Accelerator Diversification · Profitability / 2026-01-21

Related Posts

  • [Research] LIG D&A (079550) – Shinhan Securities | 4Q25 One-off Shock · KRW 26.2T Backlog · Long-term Structural Growth / 2026-02-20 Research
  • [Research] Alteogen (196170) – Shinhan Securities | Record 3 Out-Licensing Deals in 2026 · Rapid Keytruda SC Rollout · H2 Clinical Pipeline Catalysts / 2026-08-06 Research
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | CAPEX Surge · Foreign Inflows · Target Price Upgrade / 2026-07-16 Research
  • [Research] SK hynix (000660 / SKHY) – Daishin | Supply Constraints · Multi-Year LTA · Shareholder Returns / 2026-04-24 Research
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Memory ASP · Server Demand · Earnings Upgrades / 2026-03-31 Research
  • [Research] Samsung SDI (006400) – Hanwha Investment & Securities | US ESS Surges · 4Q LFP Ramp-Up · Cyclical Bottom Passed / 2026-02-03 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Hyperscaler Capex · Custom HBM · Inference Memory Demand / 2026-05-04 Research
  • [Research] Samsung Electro-Mechanics (009150) – Kiwoom Securities | Non-Commodity Shift · Structural Shortage · Price Cycle / 2026-07-31 Research
  • [Research] Alteogen (196170) – Daishin Securities | Keytruda Qlex Commercial Milestones · RNA Modality Expansion · Platform Re-rating / 2026-08-10 Research
  • [Research] Celltrion (068270) – IBK Securities | New Biosimilar Mix Expansion · Operating Leverage · H2 Margin Expansion / 2026-05-07 Research
  • [Research] ABL Bio (298380) – Mirae Asset Securities | BBB Shuttle Re-rating · IGF1R Competitiveness · ABL001 Data Readout / 2026-03-26 Research
  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Profit Turnaround / 2026-06-30 Research
  • [Research] Samsung Electro-Mechanics (009150) – iM Securities | Silicon Capacitor LTA · Fabless Model · SOTP Re-rating / 2026-05-21 Research
  • [Research] LIG D&A (079550) – Hana Securities | 1Q26 Earnings Beat · Backlog Re-rating · High-margin Follow-on Services / 2026-05-08 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme